Clinical correlates of index values in the focus HerpeSelect ELISA for antibodies to herpes simplex virus type 2 (HSV-2)

J Clin Virol. 2006 Jun;36(2):141-5. doi: 10.1016/j.jcv.2006.02.006. Epub 2006 May 4.

Abstract

Background: Clinical correlates of HerpeSelect ELISA index values are poorly understood.

Objectives: This study was designed to determine the effects of time of infection, test variability, and antibody avidity on index values.

Study design: Sera (N=313) from 81 patients with new HSV-2 infections and 236 sera from 32 patients with long-standing (median 11.3 years) HSV-2 were tested by HerpeSelect HSV-2 ELISA. High positive, low positive and negative controls were run on 42 test plates to establish test variability.

Results: Index values tended to rise after infection, peaking a median of 9-10 weeks post-infection (range 8-323 days). Of 32 patients with established HSV-2 infections, 7 (22%) had at least one low index value (>1.1 to < or =3.5), and one had a transient seroreversion event. Test variability of index values was substantially lower than inter- or intra-patient variability. Median antibody avidity was higher in sera with high versus low index values in established infections, but unrelated to index value in patients with early infections.

Conclusions: Index values or index value changes are not absolute indicators of early versus established HSV-2 infection or solely a function of test variability. Low antibody avidity may contribute to low index values once infection is established.

Publication types

  • Comparative Study

MeSH terms

  • Antibodies, Viral / blood*
  • Antibodies, Viral / immunology
  • Antibody Affinity
  • Enzyme-Linked Immunosorbent Assay / standards*
  • Herpes Genitalis / blood*
  • Herpesvirus 2, Human / immunology*
  • Humans
  • Outpatient Clinics, Hospital
  • Predictive Value of Tests*
  • Reagent Kits, Diagnostic / standards*
  • Time Factors
  • United States

Substances

  • Antibodies, Viral
  • Reagent Kits, Diagnostic